Market Overview:
The global antibody library technology market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for monoclonal antibodies (mAbs) and rising investments in R&D by biopharmaceutical companies. The global antibody library technology market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into phage display, ribosome display, yeast display, and mammalian cell surface display. The phage display segment is expected to account for the largest share of the global antibody library technology market in 2018 owing to its advantages such as high specificity and affinity for antigen binding as well as easy scalability.
Product Definition:
Antibody library technology is the process of creating a library of antibodies from a diversity of sources. This technology is important because it allows for the generation of large numbers of antibodies that can be used for research and diagnostic purposes.
Phage Display:
Phage display is a method of selecting and screening antibody binding proteins from large libraries for their ability to bind an antigen. It is based on the principle that antibodies can be displayed on the surface of phage particles, which are then used in immunoassays. The selection process involves only one step as opposed to other methods involving several steps such as chromatography, ELISA etc., making it easier and faster.
Ribosome Display:
Ribosome Display is a new technology that allows the users to view and analyze the protein sequence of an antibody with high accuracy and precision. It also helps in generating antibodies from libraries for research purposes. The technology is based on fluorescent proteins, which are attached to the RNA or DNA probes by linker sequences. These probes are then hybridized with target genes in a solution containing dextran sulfate, polyamine dyes or any other suitable stabilizing agents.
Application Insights:
The research institutes application segment accounted for the largest revenue share in 2017. This is attributed to the extensive usage of monoclonal antibodies (mAbs) in research activities at Institutes and Research Centers. mAbs are extensively used for immunological analysis, drug discovery, diagnostics and therapeutics development. The other applications include biopharmaceutical companies that develop therapeutic proteins from human antibody libraries using phage display or mammalian cell surface display techniques.
Antibody technology has numerous applications across various industry verticals including diagnostics, therapeutics, vaccines & immunoprophylaxis and others which includes bio-based products such as enzymes and polymers derived from antibodies.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of biopharmaceutical and academic research organizations engaged in drug discovery and development. Moreover, these players are also involved in collaborating with other companies for generating new leads or therapeutic proteins using AGAT. For instance, Novartis AG has entered into collaboration with Pfizer Inc., for developing novel therapies using phage display technology (Novartis press release; March 15, 2015).
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to rising investments by pharmaceutical companies as well as government funding agencies for accelerating protein drug discovery processes through advanced techniques such as protein array technology (ADT). In addition, increasing awareness about this technique among researchers from different parts of the world will drive growth further.
Growth Factors:
- Increasing demand for antibody-based therapeutics and diagnostics
- Growing number of biotechnology and pharmaceutical companies investing in antibody technology research
- Advances in screening technologies and automation that are increasing the efficiency of antibody discovery
- Proliferation of next-generation sequencing (NGS) platforms that is facilitating large scale sequencing of immunoglobulin genes
- Rising prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases which is driving the need for better diagnostic tools
Scope Of The Report
Report Attributes
Report Details
Report Title
Antibody Library Technology Market Research Report
By Type
Phage Display, Ribosome Display, Yeast Display, Mammalian Cell Surface Display
By Application
Biopharmaceutical, Research Institute, Other
By Companies
AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen Inc, Adimab LLC, AbCheck s.r.o., Philogen S.p. A., Creative-Biolabs, Invenra Inc, Abgent Inc (WuXi AppTec company), AxioMx Inc, Vaccinex Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Antibody Library Technology Market Report Segments:
The global Antibody Library Technology market is segmented on the basis of:
Types
Phage Display, Ribosome Display, Yeast Display, Mammalian Cell Surface Display
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical, Research Institute, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AnaptysBio Inc
- MorphoSys AG
- XOMA Corporation
- Abzena Plc
- AvantGen Inc
- Adimab LLC
- AbCheck s.r.o.
- Philogen S.p. A.
- Creative-Biolabs
- Invenra Inc
- Abgent Inc (WuXi AppTec company)
- AxioMx Inc
- Vaccinex Inc
Highlights of The Antibody Library Technology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Phage Display
- Ribosome Display
- Yeast Display
- Mammalian Cell Surface Display
- By Application:
- Biopharmaceutical
- Research Institute
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antibody Library Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antibody library technology (ALT) is a process for creating and managing large collections of antibodies. ALT can help researchers identify new targets for drug development, improve the accuracy of diagnostic tests, and develop new treatments for diseases.
Some of the major players in the antibody library technology market are AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen Inc, Adimab LLC, AbCheck s.r.o., Philogen S.p. A., Creative-Biolabs, Invenra Inc, Abgent Inc (WuXi AppTec company), AxioMx Inc, Vaccinex Inc.
The antibody library technology market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibody Library Technology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antibody Library Technology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antibody Library Technology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antibody Library Technology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antibody Library Technology Market Size & Forecast, 2018-2028
4.5.1 Antibody Library Technology Market Size and Y-o-Y Growth
4.5.2 Antibody Library Technology Market Absolute $ Opportunity
Chapter 5 Global Antibody Library Technology Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antibody Library Technology Market Size Forecast by Type
5.2.1 Phage Display
5.2.2 Ribosome Display
5.2.3 Yeast Display
5.2.4 Mammalian Cell Surface Display
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antibody Library Technology Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antibody Library Technology Market Size Forecast by Applications
6.2.1 Biopharmaceutical
6.2.2 Research Institute
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antibody Library Technology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antibody Library Technology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antibody Library Technology Analysis and Forecast
9.1 Introduction
9.2 North America Antibody Library Technology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antibody Library Technology Market Size Forecast by Type
9.6.1 Phage Display
9.6.2 Ribosome Display
9.6.3 Yeast Display
9.6.4 Mammalian Cell Surface Display
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antibody Library Technology Market Size Forecast by Applications
9.10.1 Biopharmaceutical
9.10.2 Research Institute
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antibody Library Technology Analysis and Forecast
10.1 Introduction
10.2 Europe Antibody Library Technology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antibody Library Technology Market Size Forecast by Type
10.6.1 Phage Display
10.6.2 Ribosome Display
10.6.3 Yeast Display
10.6.4 Mammalian Cell Surface Display
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antibody Library Technology Market Size Forecast by Applications
10.10.1 Biopharmaceutical
10.10.2 Research Institute
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antibody Library Technology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antibody Library Technology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antibody Library Technology Market Size Forecast by Type
11.6.1 Phage Display
11.6.2 Ribosome Display
11.6.3 Yeast Display
11.6.4 Mammalian Cell Surface Display
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antibody Library Technology Market Size Forecast by Applications
11.10.1 Biopharmaceutical
11.10.2 Research Institute
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antibody Library Technology Analysis and Forecast
12.1 Introduction
12.2 Latin America Antibody Library Technology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antibody Library Technology Market Size Forecast by Type
12.6.1 Phage Display
12.6.2 Ribosome Display
12.6.3 Yeast Display
12.6.4 Mammalian Cell Surface Display
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antibody Library Technology Market Size Forecast by Applications
12.10.1 Biopharmaceutical
12.10.2 Research Institute
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antibody Library Technology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antibody Library Technology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antibody Library Technology Market Size Forecast by Type
13.6.1 Phage Display
13.6.2 Ribosome Display
13.6.3 Yeast Display
13.6.4 Mammalian Cell Surface Display
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antibody Library Technology Market Size Forecast by Applications
13.10.1 Biopharmaceutical
13.10.2 Research Institute
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antibody Library Technology Market: Competitive Dashboard
14.2 Global Antibody Library Technology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AnaptysBio Inc
14.3.2 MorphoSys AG
14.3.3 XOMA Corporation
14.3.4 Abzena Plc
14.3.5 AvantGen Inc
14.3.6 Adimab LLC
14.3.7 AbCheck s.r.o.
14.3.8 Philogen S.p. A.
14.3.9 Creative-Biolabs
14.3.10 Invenra Inc
14.3.11 Abgent Inc (WuXi AppTec company)
14.3.12 AxioMx Inc
14.3.13 Vaccinex Inc
